CHICAGO, Jan. 8, 2025 — CME Group, the world’s leading derivatives marketplace, today announced its […]
Month: January 2025
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
CRANFORD, N.J., Jan. 8, 2025 — Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or […]
Novelis Announces Senior Notes Offering
ATLANTA, Jan. 8, 2025 — Novelis Inc. (“Novelis”), a leading sustainable aluminum solutions provider and […]
Azul Announces Early Participation Results for the Previously Announced Exchange Offer in respect of Existing 2028 First Out Notes for New Notes and Solicitation of Consents to Proposed Amendments to the Existing Indenture
SÃO PAULO, Jan. 8, 2025 — Azul S.A., “Azul,” (B3: AZUL4, NYSE: AZUL) (“Azul”) today […]
Azul Announces Early Participation Results for the Previously Announced Exchange Offers in respect of Existing 2029 Second Out Notes and Existing 2030 Second Out Notes for New Notes and Solicitations of Consents to Proposed Amendments to the Existing Indenture
SÃO PAULO, Jan. 8, 2025 — Azul S.A., “Azul,” (B3: AZUL4, NYSE: AZUL) (“Azul”) today announced […]
Total Play Commences Exchange Offer and Consent Solicitation
MEXICO CITY, Jan. 8, 2025 — Total Play Telecomunicaciones, S.A.P.I. de C.V. (“Total Play,” […]
Summit Midstream Corporation Announces Pricing of Offering of $250 Million of Additional 8.625% Senior Secured Second Lien Notes Due 2029
HOUSTON, Jan. 7, 2025 — Summit Midstream Corporation (NYSE: SMC) (“SMC” or the “Company”) announced […]
Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
STATEN ISLAND, N.Y., Jan. 7, 2025 — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“we” or […]
Digital Realty Announces Pricing of €850 million of Guaranteed Notes due 2035
DALLAS, Jan. 7, 2025 — Digital Realty (NYSE: DLR), the largest global provider of cloud- […]